Portage Biotech Inc. Files 6-K Report
Ticker: ATON · Form: 6-K · Filed: Dec 13, 2024 · CIK: 1095435
| Field | Detail |
|---|---|
| Company | Portage Biotech INC. (ATON) |
| Form Type | 6-K |
| Filed Date | Dec 13, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, registration-statement
TL;DR
Portage Biotech Inc. filed a 6-K on 12/13/24, incorporating into its S-8 registration statement.
AI Summary
Portage Biotech Inc. filed a Form 6-K on December 13, 2024, to report information for the month of December 2024. The filing is incorporated by reference into its Form S-8 registration statement (File No. 333-275842). The company is registered under the 1934 Act with SEC file number 001-40086.
Why It Matters
This filing indicates ongoing reporting activity for Portage Biotech Inc., which is relevant for investors tracking the company's compliance and disclosures.
Risk Assessment
Risk Level: low — This is a routine filing (Form 6-K) that primarily serves to incorporate previous information into a registration statement, with no new material financial or operational information disclosed.
Key Numbers
- 001-40086 — SEC File Number (Identifies the company's registration with the SEC.)
- 333-275842 — Form S-8 File Number (Indicates incorporation by reference into this specific registration statement.)
Key Players & Entities
- Portage Biotech Inc. (company) — Filer of the Form 6-K
- 001-40086 (company) — SEC File Number
- 333-275842 (company) — Form S-8 File Number
- December 13, 2024 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is filed for the month of December 2024 and is incorporated by reference into Portage Biotech Inc.'s registration statement on Form S-8 (File No. 333-275842).
What is Portage Biotech Inc.'s SEC file number?
Portage Biotech Inc.'s SEC file number is 001-40086.
When was this Form 6-K filed?
This Form 6-K was filed on December 13, 2024.
Does Portage Biotech Inc. file annual reports under Form 20-F or 40-F?
The filing indicates that Portage Biotech Inc. files annual reports under cover of Form 20-F.
What is the company's principal executive office address?
The company's principal executive office is located at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110.
Filing Stats: 243 words · 1 min read · ~1 pages · Grade level 11.1 · Accepted 2024-12-13 16:15:37
Filing Documents
- f6k_121324.htm (6-K) — 8KB
- 0001171843-24-006941.txt ( ) — 9KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December, 2024 Commission File Number: 001-40086 Portage Biotech Inc. (Translation of registrant’s name into English) Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F INCORPORATION BY REFERENCE This report on Form 6-K (including any exhibits attached hereto) shall be deemed to be incorporated by reference into the registration statement on Form S-8 (File No. 333-275842) of Portage Biotech Inc. (including any prospectuses forming a part of such registration statement) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. Alexander Pickett was appointed Chief Executive Officer of Portage Biotech, Inc (the “Company”), effective December 15, 2024. Further, Mr. Pickett was appointed to the Company’s Board of Directors, effective December 15, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: December 13, 2024 PORTAGE BIOTECH INC. By: /s/ Andrea Park Andrea Park Chief Financial Officer